Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Using proteomic profiling to characterize protein signatures of different thymoma subtypes.

Lai LC, Sun QL, Chen YA, Hsiao YW, Lu TP, Tsai MH, Zhu L, Chuang EY, Fang W.

BMC Cancer. 2019 Aug 13;19(1):796. doi: 10.1186/s12885-019-6023-4.

2.

Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification.

Sun QL, Fang WT, Feng J, Zhang J, Yang XH, Gu ZT, Zhu L, Sha HF.

Chin Med J (Engl). 2012 Aug;125(16):2811-8.

PMID:
22932072
3.

Proteomic Signatures of Thymomas.

Wang L, Branson OE, Shilo K, Hitchcock CL, Freitas MA.

PLoS One. 2016 Nov 10;11(11):e0166494. doi: 10.1371/journal.pone.0166494. eCollection 2016.

4.

[Histologic subtyping and prognosis of thymoma: a study of 108 cases].

Jiao X, Yin HL, Lu ZF, Zhao YC, Zhou XJ.

Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):445-9. Chinese.

PMID:
19035114
5.

Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.

Pfister F, Hussain H, Belharazem D, Busch S, Simon-Keller K, Becker D, Pfister E, Rieker R, Ströbel P, Marx A.

Histopathology. 2017 Apr;70(5):693-703. doi: 10.1111/his.13114. Epub 2017 Jan 18.

PMID:
27791295
6.

WHO histologic classification is a prognostic indicator in thymoma.

Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, Miyoshi T, Sakiyama S, Mukai K, Monden Y.

Ann Thorac Surg. 2004 Apr;77(4):1183-8.

PMID:
15063231
7.

[Correlations of novel histological classification of 82 thymoma patients to their clinical characteristics and prognosis].

Su XD, Rong TH, Long H, He JH, Zhang LJ, Zhang X, Zhao JM.

Ai Zheng. 2005 Nov;24(11):1363-6. Chinese.

PMID:
16552964
8.

Response to treatment of myasthenia gravis according to clinical subtype.

Akaishi T, Suzuki Y, Imai T, Tsuda E, Minami N, Nagane Y, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Murai H, Aoki M, Utsugisawa K.

BMC Neurol. 2016 Nov 17;16(1):225.

9.

Diagnostic reproducibility of thymic epithelial tumors using the World Health Organization classification: note for thoracic clinicians.

Sakakura N, Tateyama H, Nakamura S, Taniguchi T, Usami N, Ishikawa Y, Kawaguchi K, Yokoi K.

Gen Thorac Cardiovasc Surg. 2013 Feb;61(2):89-95. doi: 10.1007/s11748-012-0187-z. Epub 2012 Dec 12.

PMID:
23229995
10.

[Is the microscopic morphology of thymoma of clinical significance?].

Szołkowska M, Langfort R, Roszkowski-Sliz K.

Pneumonol Alergol Pol. 2005;73(2):153-9. Polish.

PMID:
16756145
11.

Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients.

Okumura M, Ohta M, Miyoshi S, Mori T, Yasumitsu T, Nakahara K, Iuchi K, Tada H, Maeda H, Matsuda H.

Jpn J Thorac Cardiovasc Surg. 2002 May;50(5):189-94. Retraction in: Jpn J Thorac Cardiovasc Surg. 2003 Jan;51(1):1 p preceding table of contents.

PMID:
12048910
12.

Type B thymoma: is prognosis predicted only by World Health Organization classification?

Kim HK, Choi YS, Kim J, Shim YM, Han J, Kim K.

J Thorac Cardiovasc Surg. 2010 Jun;139(6):1431-1435.e1. doi: 10.1016/j.jtcvs.2009.10.024. Epub 2009 Dec 28.

13.

[Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].

Ma YQ, Zhang C, Cui WL, Gulinaer A, Zhang W, Wang J.

Zhonghua Bing Li Xue Za Zhi. 2011 Dec;40(12):820-4. Chinese.

PMID:
22336207
14.

Prognosis and therapeutic response according to the World Health Organization histological classification in advanced thymoma.

Tagawa T, Kometani T, Yamazaki K, Okamoto T, Wataya H, Seto T, Fukuyama S, Osoegawa A, Hirai F, Sugio K, Ichinose Y.

Surg Today. 2011 Dec;41(12):1599-604. doi: 10.1007/s00595-011-4522-2. Epub 2011 Oct 4.

PMID:
21969191
15.

[Combined thymoma (AB + B)--pathological diagnosis and clinical significance].

Chen G.

Zhonghua Bing Li Xue Za Zhi. 2002 Oct;31(5):416-9. Chinese.

PMID:
12485483
16.

An immunohistochemical panel consisting of EZH2, C-KIT, and CD205 is useful for distinguishing thymic squamous cell carcinoma from type B3 thymoma.

Kim BS, Kim JK, Kang CH, Kim YT, Jung KC, Won JK.

Pathol Res Pract. 2018 Mar;214(3):343-349. doi: 10.1016/j.prp.2018.01.009. Epub 2018 Feb 24.

PMID:
29487009
17.

Proliferative activity and apoptosis in thymic epithelial neoplasms.

Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H.

Mod Pathol. 2002 Dec;15(12):1326-32.

18.

[Clinicopathologic analysis of 52 cases of thymic epithelial tumor].

Ma YQ, Miao N, Abulajiang G, Li QX, Liu X, Zhang W, Wang CF, Wang J.

Zhonghua Bing Li Xue Za Zhi. 2010 Apr;39(4):249-54. Chinese.

PMID:
20654124
19.

Diagnosis of thymic epithelial tumor subtypes by a quantitative proteomic approach.

Zhao T, Wu J, Liu X, Zhang L, Chen G, Lu H.

Analyst. 2018 May 29;143(11):2491-2500. doi: 10.1039/c8an00218e.

PMID:
29645059
20.

Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka.

Penzel R, Hoegel J, Schmitz W, Blaeker H, Morresi-Hauf A, Aulmann S, Hecker E, Mechtersheimer G, Otto HF, Rieker RJ.

Int J Cancer. 2003 Jul 1;105(4):494-8.

Supplemental Content

Support Center